Financials

News Ideas Discussions Technicals Seasonals

Total liabilities & shareholders' equities of Regencell Bioscience Holdings Limited

Annual data

2020

2021

2022

2023

2024

‪0.00‬

‪‪5.00 M‬‬

‪‪10.00 M‬‬

‪‪15.00 M‬‬

‪‪20.00 M‬‬

Period

Value

Change

Change %

2024

‪‪8.44 M‬‬

‪‪−4.18 M‬‬

‪−33.15‬%

2023

‪‪12.62 M‬‬

‪‪−5.40 M‬‬

‪−29.95‬%

2022

‪‪18.02 M‬‬

+‪‪17.68 M‬‬

+‪‪5.20 K‬‬%

2021

‪‪340.13 K‬‬

‪‪−173.88 K‬‬

‪−33.83‬%

2020

‪‪514.02 K‬‬

+‪‪270.71 K‬‬

+‪111.26‬%

Semiannual data

H2 '22

H1 '23

H2 '23

H1 '24

H2 '24

‪0.00‬

‪‪5.00 M‬‬

‪‪10.00 M‬‬

‪‪15.00 M‬‬

‪‪20.00 M‬‬

Period

Value

Change

Change %

H2 '24

‪‪8.44 M‬‬

‪‪−2.04 M‬‬

‪−19.45‬%

H1 '24

‪‪10.48 M‬‬

‪‪−2.15 M‬‬

‪−17.01‬%

H2 '23

‪‪12.62 M‬‬

‪‪−2.93 M‬‬

‪−18.82‬%

H1 '23

‪‪15.55 M‬‬

‪‪−2.47 M‬‬

‪−13.71‬%

H2 '22

‪‪18.02 M‬‬

—

—